Catimel G - Search Results

1

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety.

Catimel G, Spielmann M, Dieras V, Kayitalire L, Pouillart P, Guastalla JP, Soler-Michel P, Graffand N, Garet F, Dumortier A, Pellae-Cosset B, Chazard M. Catimel G, et al. Semin Oncol. 1996 Feb;23(1 Suppl 1):24-7. Semin Oncol. 1996. PMID: 8629032 Clinical Trial.

2

FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy.

Catimel G, Chauvin F, Guastalla JP, Rebattu P, Biron P, Clável M. Catimel G, et al. Ann Oncol. 1994 Jan;5(1):95-7. doi: 10.1093/oxfordjournals.annonc.a058707. Ann Oncol. 1994. PMID: 8172802 Free article.

3

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.

Catimel G, Spielmann M, Dieras V, Tubiana-Hulin M, Bonneterre J, Pouillart P, Kayitalire L, Guastalla JP, Graffand N, Garet F, Dumortier A, Pellae-Cosset B. Catimel G, et al. Semin Oncol. 1997 Feb;24(1 Suppl 3):S8-12. Semin Oncol. 1997. PMID: 9071333 Clinical Trial.

4

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors.

Catimel G, Chabot GG, Guastalla JP, Dumortier A, Cote C, Engel C, Gouyette A, Mathieu-Boué A, Mahjoubi M, Clavel M. Catimel G, et al. Ann Oncol. 1995 Feb;6(2):133-40. doi: 10.1093/oxfordjournals.annonc.a059108. Ann Oncol. 1995. PMID: 7786821 Free article. Clinical Trial.

5

Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors.

Catimel G, Coquard R, Guastalla JP, Merrouche Y, Le Bail N, Alakl MK, Dumortier A, Foy M, Clavel M. Catimel G, et al. Cancer Chemother Pharmacol. 1995;35(3):246-8. doi: 10.1007/BF00686555. Cancer Chemother Pharmacol. 1995. PMID: 7805184 Clinical Trial.

6

A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapy.

Merrouche Y, Catimel G, Rebattu P, Dumortier A, Guastalla JP, O'Grady P, Clavel M. Merrouche Y, et al. Among authors: catimel g. Ann Oncol. 1994 Jul;5(6):549-51. doi: 10.1093/oxfordjournals.annonc.a058911. Ann Oncol. 1994. PMID: 7918128 Free article. Clinical Trial.

7

Phase II trial of navelbine and fluorouracil as second-line chemotherapy in metastatic breast carcinoma.

Froudarakis ME, Catimel G, Guastalla JP, Rebattu P, Clavel M. Froudarakis ME, et al. Among authors: catimel g. Oncology. 1998 Jan-Feb;55(1):87-8. doi: 10.1159/000011840. Oncology. 1998. PMID: 9428381 Clinical Trial. No abstract available.

8

Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.

Ray-Coquard I, Biron P, Bachelot T, Guastalla JP, Catimel G, Merrouche Y, Droz JP, Chauvin F, Blay JY. Ray-Coquard I, et al. Among authors: catimel g. Cancer. 1998 Jan 1;82(1):134-40. Cancer. 1998. PMID: 9428489

9

Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.

Tranchand B, Catimel G, Lucas C, Sarkany M, Bastian G, Evene E, Guastalla JP, Négrier S, Rebattu P, Dumortier A, Foy M, Grossin F, Mazier B, Froudarakis M, Barbet N, Clavel M, Ardiet C. Tranchand B, et al. Among authors: catimel g. Cancer Chemother Pharmacol. 1998;41(4):281-91. doi: 10.1007/s002800050741. Cancer Chemother Pharmacol. 1998. PMID: 9488597 Clinical Trial.

10

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials.

Bachelot T, Ray-Coquard I, Catimel G, Ardiet C, Guastalla JP, Dumortier A, Chauvin F, Droz JP, Philip T, Clavel M. Bachelot T, et al. Among authors: catimel g. Ann Oncol. 2000 Feb;11(2):151-6. doi: 10.1023/a:1008368319526. Ann Oncol. 2000. PMID: 10761748 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters